Breaking News : India's fastest news agency in pharmaceutical, biotechnology & medical news
Bharat Biotech, which had sought DCGI’s approval to conduct phase-3 clinical trials of Covaxin, COVID-19 vaccine candidate, has been asked to submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing...
Scientists in the UK will begin recruiting frontline healthcare workers to test if an old vaccine used to combat tuberculosis (TB), the Bacillus Calmette-Guerin or BCG jab, can be repurposed to help boost immunity...
India already had a high but under-treated burden of mental illnesses, but with COVID 19 ushering in a prolonged state of threat, uncertainty and insecurity, we are witnessing a significant rise in cases of...
Axovant Gene Therapies Ltd., a clinical-stage company developing innovative gene therapies for neurological diseases, announced that it has received Rare Pediatric Disease Designation from the US Food and Drug Administration (FDA) for AXO-AAV-GM1, an...
Grifols, a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing people’s health and well-being, announced that its anti-SARS-CoV-2 hyperimmune globulin,...
Beaufond PLC has initiated series of corporate programs to increase productivity, efficiency & work performance. To respond best to the changes driven by the COVID-19 pandemic, Beaufond PLC is initiating measures to reorient effective...
Beaufond Foundation, a charity dedicated to supporting underprivileged disabled children, will initiate several measures& steps using the technology to implement latest AI software as part of its strategy to drive efficiencies and become a...
Winkle Capital, a unit of Winkle Group has proposed to announce the creation of $1 Billion program for Retail Investors in Europe to bring much needed capital and assist with the recapitalization of retail...
Recent Comments